Skip to main content
Clinical Trials/NCT03734159
NCT03734159
Completed
Phase 4

Interest of Parasternal Block to Limit the Doses of Anesthetics Necessary for the Maintenance of Arterial Blood Pressure and Heart Rate in the Recommended Values During Sternotomy in Patients Undergoing Coronary Artery Bypass Graft

CMC Ambroise Paré1 site in 1 country35 target enrollmentDecember 13, 2018

Overview

Phase
Phase 4
Intervention
Ropivacaine
Conditions
Coronary Bypass Graft Stenosis
Sponsor
CMC Ambroise Paré
Enrollment
35
Locations
1
Primary Endpoint
Show that the preoperative realization of a parasternal block limites the posology of remifentanil administered during sternotomies to maintain blood pressure and heart rate within recommended ranges
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Patients undergoing coronary artery bypass grafting are at risk for perioperative myocardial ischemia. Episodes of tachycardia and hypertension, which are associated with an increase in myocardial oxygen consumption, are predictive events of these ischemia.

During cardiac surgery by sternotomy, some maneuvers, e.g. intubation, skin incision, sternotomy and cannulation, may be associated with tachycardia and/or increases in blood pressure despite an adequate level of anesthesia. Usually these episodes are controlled by the administration of a high-dose of anesthetic agents.

The parasternal block, by bolus or continuous infusion through a single catheter, showed its effectiveness on postoperative pain after sternotomy. It allows a blocking of anterior branches of intercostal nerves at the lateral edge of the sternum; branches in charge of innervation of the sternum and the overlying skin surface.

The preoperative parasternal block, once general anesthesia performed, could provide an effective level of locoregional anesthesia of the chest wall, thus limiting the occurrence of episodes of tachycardia and / or hypertension without having to resort to massive doses of anesthetic agents during sternotomy in patients undergoing coronary bypass surgery.

Detailed Description

This randomized double blinded placebo-controlled clinical trial will include patients undergoing coronary artery bypass grafting. Locoregional anesthesia of the chest wall will be performed under ultrasound, once general anesthesia performed. A total volume of 60 ml of sodium chloride 0.9% (placebo group) or ropivacaine 0.25% (experimental group) divided into 4 injections of 15 ml (2 per side, between ribs 2 and 3 and between ribs 4 and 5) will be injected.

Registry
clinicaltrials.gov
Start Date
December 13, 2018
End Date
November 7, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
CMC Ambroise Paré
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing coronary artery bypass graft requiring sternotomy other than re-interventions and combined surgeries
  • Consent for participation
  • Affiliation to the french social security system

Exclusion Criteria

  • Pregnant or breastfeeding women
  • Patients under protection of the adults (guardianship, curator or safeguard of justice)
  • Communication difficulties or neuropsychiatric disorder
  • Neuropathic disease
  • Constitutional coagulation disorders
  • Kidney insufficiency
  • Sensitivity to nonsteroidal anti-inflammatory drugs
  • Hypersensitivity to local anaesthetics
  • Chronic use of opioid analgesics
  • Corticosteroid treatment or immunosuppressive therapy

Arms & Interventions

parasternal block

preoperative parasternal block by ropivacaine injection

Intervention: Ropivacaine

physiological serum

sodium chloride injection

Intervention: sodium chloride 0.9%

Outcomes

Primary Outcomes

Show that the preoperative realization of a parasternal block limites the posology of remifentanil administered during sternotomies to maintain blood pressure and heart rate within recommended ranges

Time Frame: Intraoperative period : from intubation to sternal retractor setup

Maximal dose of remifentanil (morphine peak) required to maintain hemodynamic parameters (arterial blood pressure and heart rate) in the appropriate values during intubation, skin incision, sternotomy and sternal retractor setup

Secondary Outcomes

  • Hemodynamic response : heart rate(Intraoperative period : from the start of general anesthesia maintenance to the fifth minute after sternal retractor setup)
  • Dose of hypnotic drug(Intraoperative period : from induction of anesthesia to skin closure)
  • Pain level during extubation: Numeric scale(8 hours)
  • Complications(7 days)
  • Hemodynamic response : arterial blood pressure(Intraoperative period : from the start of general anesthesia maintenance to the fifth minute after sternal retractor setup)
  • Hemodynamic response : patient state index(Intraoperative period : from the start of general anesthesia maintenance to the fifth minute after sternal retractor setup)
  • Dose of analgesic drug(Intraoperative period : from induction of anesthesia to skin closure)
  • Inflammatory response(7 days)

Study Sites (1)

Loading locations...

Similar Trials